PI BIOGRAPHY
Dr. Ohashi received her PhD from the University of Toronto with Dr. Tak Mak, and did her post-doctoral training at the University of Zurich with the Nobel Laureate Dr. Rolf Zinkernagel, and Dr. Hans Hengartner. She is a Senior Scientist at the Princess Margaret Cancer Centre, and Professor in the Department of Immunology at the University of Toronto. She is also the Director of the Tumor Immunotherapy Program at the Princess Margaret Cancer Centre.
Dr. Ohashi’s research interests is focussed on understanding CD8 T cell immunobiology as well as the impact of innate lymphoid cells in tumor immunology with a perspective on improving immunotherapy.
Dr. Ohashi has received a number of prestigious awards and honors including the American Association of Immunologists (AAI) Pharmingen Investigator Award, the National Cancer Institute of Canada’s William E. Rawls Award, The Canadian Society of Immunology’s Investigator Award as well as a Tier 1 Canada Research Chair. She previously served as the Chair of the Cancer Immunotherapy Steering Committee of the American Association for Cancer Research (AACR), and AACR(CIMM) chair-elect of the Nominating committee. She also previously served on the Board of Directors of the Society for Immunotherapy of Cancer (SITC). She has also been elected as a member of the Royal Society of Canada.
Senior Scientist, Princess Margaret Cancer Centre
Director, Tumor Immunotherapy Program (TIP)
Professor, Department of Immunology, Faculty of Medicine, University of Toronto
Dr. Ohashi received her PhD from the University of Toronto with Dr. Tak Mak, and did her post-doctoral training at the University of Zurich with the Nobel Laureate Dr. Rolf Zinkernagel, and Dr. Hans Hengartner. She is a Senior Scientist at the Princess Margaret Cancer Centre, and Professor in the Department of Immunology at the University of Toronto. She is also the Director of the Tumor Immunotherapy Program at the Princess Margaret Cancer Centre.
Dr. Ohashi’s research interests is focussed on understanding CD8 T cell immunobiology as well as the impact of innate lymphoid cells in tumor immunology with a perspective on improving immunotherapy.
Dr. Ohashi has received a number of prestigious awards and honors including the American Association of Immunologists (AAI) Pharmingen Investigator Award, the National Cancer Institute of Canada’s William E. Rawls Award, The Canadian Society of Immunology’s Investigator Award as well as a Tier 1 Canada Research Chair. She previously served as the Chair of the Cancer Immunotherapy Steering Committee of the American Association for Cancer Research (AACR), and AACR(CIMM) chair-elect of the Nominating committee. She also previously served on the Board of Directors of the Society for Immunotherapy of Cancer (SITC). She has also been elected as a member of the Royal Society of Canada.
Senior Scientist, Princess Margaret Cancer Centre
Director, Tumor Immunotherapy Program (TIP)
Professor, Department of Immunology, Faculty of Medicine, University of Toronto
|
|
|
|